Vertex Oncology Dr Giri

  Completing cancer treatment is a significant milestone worth celebrating. Whether a patient has undergone surgery, chemotherapy, radiation therapy, immunotherapy, or a combination of treatments, reaching the end of active treatment often brings relief and hope. However, the end of treatment does not mean the end of cancer care. Regular follow-up appointments with an oncologist remain an essential part of survivorship. These visits play a critical role in monitoring health, managing long-term effects, detecting recurrence early, and providing emotional reassurance during the transition back to everyday life. How Often Should Cancer Survivors Follow Up with Their Oncologist? Follow-up schedules vary depending on the type of cancer, stage at diagnosis, treatment received, and the patient's overall health. In general: During the first 2–3 years after treatment, follow-up visits are often scheduled every 3 months. Between years 3–5, appointments may occur every 4 months. After 5 years...

Breast cancer is the most common cancer among women worldwide and is increasingly being diagnosed in Indian women. While many women are aware of mammography and breast self-examination, fewer know that modern medicine can estimate an individual's future risk of developing breast cancer. One of the most advanced tools available today is the Tyrer-Cuzick Model , also known as the IBIS Breast Cancer Risk Assessment Tool . This model helps doctors identify women who may have a higher-than-average risk of developing breast cancer and guides decisions regarding screening, genetic testing, and preventive strategies. What Is the Tyrer-Cuzick Model? The Tyrer-Cuzick Model is a scientifically validated risk assessment tool used to estimate a woman's likelihood of developing breast cancer over the next 10 years and throughout her lifetime. Unlike older risk calculators, the Tyrer-Cuzick Model considers a wide range of personal, family, and hormonal factors, making it one of the most compr...

  Introduction Breast cancer is now one of the most common cancers affecting women worldwide. Many women ask an important question: "What are my chances of developing breast cancer?" While no one can predict the future with complete certainty, doctors use scientific tools to estimate an individual's risk. One of the most widely used tools is called the Gail Model . The Gail Model helps estimate a woman's likelihood of developing breast cancer over the next 5 years and during her lifetime. It can guide decisions about screening, prevention, and lifestyle changes. What Is the Gail Model? The Gail Model is a breast cancer risk assessment tool developed by researchers in the United States. It uses information about a woman’s personal and family history to calculate her risk of developing invasive breast cancer. Think of it as a "breast cancer risk calculator" that helps doctors identify women who may benefit from closer monitoring or preventive strategies. What ...

  1. Mammography (Current Gold Standard) Mammography Sensitivity: 75–90% (lower in dense breasts) Specificity: 90–95% Advantages Proven to reduce breast cancer mortality. Detects tiny calcifications before a lump develops. Can identify cancers 1–3 years before symptoms appear. Limitations Less effective in women with dense breasts. False positives can occur. Recommended Most guidelines recommend screening from age 40–50 years onward, depending on risk factors. 2. Breast MRI (Highest Sensitivity) Breast MRI Sensitivity: 90–99% Specificity: 72–90% Advantages Most sensitive imaging test available. Detects cancers missed by mammography. Particularly useful in women with: BRCA mutations Strong family history Very dense breasts Limitations More false positives. Expensive. Not recommended for routine screening of average-risk women. 3. Digital Breast Tomosynthesis (3D Mammography) Digital Breast Tomosynthesis Sensitivity: Slightly higher than st...

 When doctors discuss cancer outcomes, one of the most commonly used statistics is the 5-year survival rate . Definition A 5-year survival rate is the percentage of patients who are alive 5 years after their cancer diagnosis , regardless of whether they are cancer-free or still receiving treatment. For example: If a cancer has a 5-year survival rate of 90% , it means that 90 out of 100 patients are alive 5 years after diagnosis . It does not necessarily mean they are cured . Some may still have cancer, while others may be completely disease-free. Why Is 5-Year Survival Used? Cancer research requires a standard way to compare outcomes. Five years is commonly used because: Many cancer recurrences happen within the first 5 years. It provides a meaningful measure of long-term treatment success. It allows comparison between hospitals, treatments, and countries. Important Limitations 1. It Does Not Predict an Individual's Outcome A survival rate is based on la...

  Introduction Imagine detecting cancer years before it causes symptoms—with nothing more than a simple blood test. It sounds like science fiction, but advances in Liquid Biopsy and Artificial Intelligence (AI)-based cancer detection are bringing us closer to that reality. Over the last few years, researchers around the world have been developing blood tests that can identify tiny traces of cancer circulating in the bloodstream. These technologies have generated tremendous excitement because they may one day allow cancers to be detected earlier, treated sooner, and cured more often. But how close are we to that goal? Can a blood test really detect cancer before symptoms start? Let's separate scientific facts from marketing hype. What Is a Liquid Biopsy? Traditionally, diagnosing cancer requires a tissue biopsy, where a sample of the tumor is removed and examined under a microscope. A liquid biopsy is different. Instead of removing tissue, doctors analyze a blood sample to look f...